BioMed Research International / 2015 / Article / Tab 4

Research Article

The Effect of Bicarbonate Administration via Continuous Venovenous Hemofiltration on Acid-Base Parameters in Ventilated Patients

Table 4

Continuous venovenous hemofiltration prescription characteristics.

All subjects
()
Bicarbonate
4K+/2.5Ca++
()
Bicarbonate
2K+/0Ca++
()
Bicarbonate
0K+/2.5Ca++
()
Citrate
()

Blood flow rate (mL/min)
 Mean ± SD238 ± 33238 ± 34244 ± 17247 ± 11175 ± 46
 Median [25th, 75th]250 250, 250]250 250, 250]250 250, 250]250 250, 250]150 150, 200]
 (min, max)(150, 250)(150, 250)(200, 250)(200, 250)(150, 250)
Solution flow rate (mL/h)
 Mean ± SD2214 ± 4842158 ± 4622220 ± 5272563 ± 4532050 ± 256
 Median [25th, 75th]2000 2000, 2400]2000 2000, 2400]2000 2000, 2400]2500 2000, 3000]2000 2000, 2200]
 (min, max)(2000, 3200)(2000, 3200)(2000, 3000)(2000, 3000)(1600, 2400)
Ultrafiltration rate (mL/h)
 Mean ± SD45 ± 6247 ± 6339 ± 5145 ± 5350 ± 53
 Median [25th, 75th]0 0, 100]10 0, 100]0 0, 100]0 0, 50]50 0, 100]
 (min, max)(0, 250)(0, 250)(0, 150)(0, 250)(0, 100)

Rates reflect average values over the course of the 96-hour study duration. represents the number of subjects on a given solution prescription at the time of CVVH initiation.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.